Regulation of TGF-β Family Signaling by Inhibitory Smads
Open accessThe DOI matches its Crossref record; 210 of the 211 references it cites were found in a registry or an index.
Abstract
Inhibitory Smads (I-Smads) have conserved carboxy-terminal MH2 domains but highly divergent amino-terminal regions when compared with receptor-regulated Smads (R-Smads) and common-partner Smads (co-Smads). Smad6 preferentially inhibits Smad signaling initiated by the bone morphogenetic protein (BMP) type I receptors ALK-3 and ALK-6, whereas Smad7 inhibits both transforming growth factor β (TGF-β)- and BMP-induced Smad signaling. I-Smads also regulate some non-Smad signaling pathways. Here, we discuss the vertebrate I-Smads, their roles as inhibitors of Smad activation and regulators of receptor stability, as scaffolds for non-Smad signaling, and their possible roles in the nucleus. We also discuss the posttranslational modification of I-Smads, including phosphorylation, ubiquitylation, acetylation, and methylation.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“RAB11 285, which is responsible for endosomal recycling of TGFβ receptors 286, is recruited to the cilium in a process that is mediated by the subdistal appendage protein, CEP128 287. Consequently, loss of CEP128 leads to impaired phosphorylation of R-SMADs, which in zebrafish is associated with defective organ development 287.”
From Cellular signalling by primary cilia in development, organ function and disease (2019) · cites this paper as [287]
In the citing paper
“Also, non-mutational mechanisms impair the growth inhibitory response to TGF-β. In advanced tumors, TGFBR2 or SMAD2 genes are frequently silenced by histone and DNA methylation122,123. Additionally, increased inhibitory Smad6 or Smad7 expression in various carcinomas, including PDAC, attenuates Smad signaling124,125, whereas increased expression of the Smad corepressors c-Ski or SnoN, observed in”
From TGFβ biology in cancer progression and immunotherapy (2021) · cites this paper as [124]
Citations
Cites
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857 · cited 1×
“TGF-b family ligands trigger signaling through hetero-oligomerization of two types of transmembrane receptors with intrinsic serine-threonine kinase activities: the type I and type II receptors (Shi and Massagué 2003).”
BackgroundIdentification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.-E., Heldin, C.-H., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,809 · cited 1×
“Among the eight different Smad proteins in vertebrates, Smad6 and Smad7 are I-Smads (Hayashi et al. 1997; Imamura et al. 1997; Nakao et al. 1997; Hata et al. 1998; Souchelnytskyi et al. 1998).”
BackgroundNon-Smad pathways in TGF-β signaling
Zhang, Y. E. (2009) · Cell Research · doi:10.1038/cr.2008.328 · Cited by 1,749 · cited 1×
“…# 2017 Cold Spring Harbor Laboratory Press; all rights reserved; doi: 10.1101/cshperspect.a022095 Cite this article as Cold Spring Harb Perspect Biol 2017;9:a022095 1 tivated receptors can transmit signals independent of Smad proteins (non-Smad signaling pathways) (Zhang 2009).”
BackgroundInfluentialIdentification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal Transduction
Yamaguchi, K., Shirakabe, K., Shibuya, H., Irie, K., Oishi, I., Ueno, N., Taniguchi, T., Nishida, E., & Matsumoto, K. (1995) · Science · doi:10.1126/science.270.5244.2008 · Cited by 1,343 · cited 1×
“TAK1 is a MAPKKK activated in response to TGF-b, interleukin-1, and several other inducers (Yamaguchi et al. 1995; Ninomiya-Tsuji et al. 1999; Shim et al. 2005).”
BackgroundHayashi, H., Abdollah, S., Qiu, Y., Cai, J., Xu, Y.-Y., Grinnell, B. W., Richardson, M. A., Topper, J. N., Gimbrone, M. A., Wrana, J. L., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80303-7 · Cited by 1,334 · cited 1×
“Among the eight different Smad proteins in vertebrates, Smad6 and Smad7 are I-Smads (Hayashi et al. 1997; Imamura et al. 1997; Nakao et al. 1997; Hata et al. 1998; Souchelnytskyi et al. 1998).”
BackgroundSMAD proteins control DROSHA-mediated microRNA maturation
Davis, B. N., Hilyard, A. C., Lagna, G., & Hata, A. (2008) · Nature · doi:10.1038/nature07086 · Cited by 1,244 · cited 1×
“Activated Smad proteins promote the maturation of miR-21 independent of Smad4 by associating with the stem region of pri-miR-21 (Davis et al. 2008).”
BackgroundSmad7 Binds to Smurf2 to Form an E3 Ubiquitin Ligase that Targets the TGFβ Receptor for Degradation
Kavsak, P., Rasmussen, R. K., Causing, C. G., Bonni, S., Zhu, H., Thomsen, G. H., & Wrana, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00134-9 · Cited by 1,205 · cited 1×
“2A) (Kavsak et al. 2000; Ebisawa et al. 2001; Murakami et al. 2003).”
Ninomiya-Tsuji, J., Kishimoto, K., Hiyama, A., Inoue, J.-I., Cao, Z., & Matsumoto, K. (1999) · Nature · doi:10.1038/18465 · Cited by 1,182 · cited 1×
“TAK1 is a MAPKKK activated in response to TGF-b, interleukin-1, and several other inducers (Yamaguchi et al. 1995; Ninomiya-Tsuji et al. 1999; Shim et al. 2005).”
BackgroundFantini, M. C., Becker, C., Monteleone, G., Pallone, F., Galle, P. R., & Neurath, M. F. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.9.5149 · Cited by 1,135 · cited 1×
“3), leading to enhanced TGF-b signaling and acquisition of regulatory properties by these cells, including an antiproliferative effect on CD4þ T cells (Fantini et al. 2004).”
BackgroundSmad6 inhibits signalling by the TGF-β superfamily
Imamura, T., Takase, M., Nishihara, A., Oeda, E., Hanai, J.-I., Kawabata, M., & Miyazono, K. (1997) · Nature · doi:10.1038/39355 · Cited by 1,029 · cited 1×
“Among the eight different Smad proteins in vertebrates, Smad6 and Smad7 are I-Smads (Hayashi et al. 1997; Imamura et al. 1997; Nakao et al. 1997; Hata et al. 1998; Souchelnytskyi et al. 1998).”
BackgroundSelf-citation
Research works printed but not linked: 1
- 10.1172/jci200112367 · doi:10.1172/jci200112367 · Paper page
Cited by
Items 101–200 of 463
Han, T., Song, P., Wu, Z., Xiang, X., Liu, Y., Wang, Y., Fang, H., Niu, Y., & Shen, C. (2021) · Stem Cell Reviews and Reports · doi:10.1007/s12015-021-10219-6 · Cited by 50
Regulation of ciliary membrane protein trafficking and signalling by kinesin motor proteins
Morthorst, S. K., Christensen, S. T., & Pedersen, L. B. (2018) · The FEBS Journal · doi:10.1111/febs.14583 · Cited by 49
Gene Ontology representation for transcription factor functions
Gaudet, P., Logie, C., Lovering, R. C., Kuiper, M. T. R., Lægreid, A., & Thomas, P. D. (2021) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2021.194752 · Cited by 52
“Well characterized examples are the I-SMADs, SMAD6 and SMAD7 (33), that act by competing with active SMADs at receptors, thus blocking further intracellular signalling, and should be annotated to "GO:0140416 transcription regulator inhibitor activity". ou It must be noted that these approaches to avoid errors in dbTF…”
BackgroundCXXC5: A novel regulator and coordinator of TGF‐β, BMP and Wnt signaling
Xiong, X., Tu, S., Wang, J., Luo, S., & Yan, X. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14046 · Cited by 49
SMAD4 Feedback Activates the Canonical TGF-β Family Signaling Pathways
Liu, L., Li, Q., Yang, L., Li, Q., & Du, X. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221810024 · Cited by 47
Endothelial-to-Mesenchymal Transition: Role in Cardiac Fibrosis
Cheng, W., Li, X., Liu, D., Cui, C., & Wang, X. (2020) · Journal of Cardiovascular Pharmacology and Therapeutics · doi:10.1177/1074248420952233 · Cited by 50
Transforming growth factor-β in tumour development
Trelford, C. B., Dagnino, L., & Guglielmo, G. M. D. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.991612 · Cited by 49
“In conclusion, cells that upregulate microRNAs that block EMT/EndMT-transcription factor translation, contain DNA methylation in the promoters of genes regulated by EMT/EndMT-transcription factors, and favour tumour suppressive TGFβ pathways are less likely to undergo TGFβ-dependent EMT/EndMT.”
BackgroundInfluentialGuo, M., Wang, Z., Dai, J., Fan, H., Yuan, N., Gao, L., Peng, H., & Cheng, X. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154587 · Cited by 48
Transforming growth factor-β signaling: from tumor microenvironment to anticancer therapy
Chan, M. K., Chan, E. L.-Y., Ji, Z. Z., Chan, A. S. W., Li, C., Leung, K. T., To, K., & Tang, P. M. (2023) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2023.00137 · Cited by 45
“I-Smads block the signaling through multiple mechanisms which serve as essential negative feedback for preventing the hyperactivation of TGF-β signaling [23].”
BackgroundCXXC5 suppresses hepatocellular carcinoma by promoting TGF-β-induced cell cycle arrest and apoptosis
Yan, X., Wu, J., Jiang, Q., Cheng, H., Han, J. J., & Chen, Y. (2017) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjx042 · Cited by 48
The dichotomous role of TGF-β in controlling liver cancer cell survival and proliferation
Zhang, K., Zhang, M., Luo, Z., Wen, Z., & Yan, X. (2020) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2020.09.005 · Cited by 46
The Multifaceted Role of TGF-β in Gastrointestinal Tumors
Sabbadini, F., Bertolini, M., Matteis, S. D., Mangiameli, D., Contarelli, S., Pietrobono, S., & Melisi, D. (2021) · Cancers · doi:10.3390/cancers13163960 · Cited by 47
Feng, X., Xiang, Q., Jia, J., Guo, T., Liao, Z., Yang, S., Cai, X., & Liu, X. (2022) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2022.02.017 · Cited by 45
“SMAD7 is an essential negative regulator in SMAD family and can antagonize the transforming growth factor b (TGF-b)/BMP signaling pathway through various molecular mechanisms.(9,10) SMAD7 has been reported to play crucial roles in the multi-differentiation process of mesenchymal stem cells, including the osteogenic di…”
BackgroundSu, C.-T., & Urbán, Z. (2021) · Genes · doi:10.3390/genes12060795 · Cited by 44
“In contrast, the two inhibitory (I-) Smads, Smad6 and Smad7, provide negative feedback control of canonical signaling [16].”
BackgroundLoh, H.-Y., Norman, B. P., Lai, K., Cheng, W.-H., Rahman, N. M. A. N. A., Alitheen, N. B., & Osman, M. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24076423 · Cited by 45
Wu, D., Yin, L., Sun, D., Wang, F., Wu, Q., Xu, Q., & Xin, B. (2020) · Archives of Oral Biology · doi:10.1016/j.archoralbio.2020.104814 · Cited by 42
RetractedChronic Systemic Inflammation Exacerbates Neurotoxicity in a Parkinson’s Disease Model
Ugalde-Muñiz, P., Fetter-Pruneda, I., Navarro, L., García, E., & Chavarría, A. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4807179 · Cited by 39
“IFNγ via STAT1 and TNFα via NFκB induce inhibitory Smad7 expression, an antagonist of TGFβ signaling pathway, thus lowering TGFβ secretion [60, 61].”
BackgroundLamprecht, S., Sigal-Batikoff, I., Shany, S., Abu-Freha, N., Ling, E., Delinasios, G. J., Moyal-Atias, K., Delinasios, J. G., & Fich, A. (2018) · Cancers · doi:10.3390/cancers10030061 · Cited by 41
“We propose SMAD7 as a likely candidate since de-acetylation of SMAD7 reduces the stability of SMAD7 and promotes its proteasomal demise [94].”
BackgroundGAS5 protects against osteoporosis by targeting UPF1/SMAD7 axis in osteoblast differentiation
Li, M., Xie, Z., Li, J., Lin, J., Guan, Z., Liu, W., Tang, S., Cen, S., Ye, G., Li, Z., et al. (2020) · eLife · doi:10.7554/elife.59079 · Cited by 43
“Studies have found that SMAD7 inhibits the SMAD1/5/8 pathway and negatively regulates the osteoblast differentiation ( Li et al., 2017 ; Miyazawa and Miyazono, 2017 ).”
BackgroundInfluentialThe role of BMP4 in adipose-derived stem cell differentiation: A minireview
Setiawan, A. M., Kamarudin, T. A., & Ghafar, N. A. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1045103 · Cited by 41
Das, S., Vraspir, L., Zhou, W., Durica, D. S., & Mykles, D. L. (2018) · Comparative Biochemistry and Physiology Part D Genomics and Proteomics · doi:10.1016/j.cbd.2018.06.001 · Cited by 41
Interplay between TGF-β signaling and receptor tyrosine kinases in tumor development
Shi, Q., & Chen, Y. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9173-5 · Cited by 40
TGF-β Family Signaling in Ductal Differentiation and Branching MorphogenesisPreprint
Kahata, K., Maturi, V., & Moustakas, A. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a031997 · Cited by 40
“The inhibitory Smad7 is known to repress signaling by TGFb and activin receptors, although it can also block BMP signaling (Miyazawa and Miyazono 2016).”
BackgroundIdentification of a TGF-β/SMAD/lnc-UTGF positive feedback loop and its role in hepatoma metastasis
Wu, M., Yuan, Y., Huang, B.-Y., Chen, J.-X., Li, B., Fang, J., & Zhuang, S. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00781-3 · Cited by 40
“The homeostasis of the TGF-β/SMAD signaling is regulated by feedback loops, like TGF-β/SMAD7 negative feedback loop, in which SMAD7 is transactivated by SMAD2/3 and then represses the TGF-β/SMAD signaling by binding to TGFβRI/II.(5) It has been shown that disruption of the TGF-β signaling contributes to tumorigenesis,…”
BackgroundGinsenoside Rg1 Epigenetically Modulates Smad7 Expression in Liver Fibrosis via MicroRNA-152
Zhang, R., Li, X., Gao, Y., Tao, Q., Lang, Z., Zhan, Y., Li, C., & Zheng, J. (2022) · Journal of Ginseng Research · doi:10.1016/j.jgr.2022.12.005 · Cited by 38
“It has been reported that Smad7 is a negative regulator of the TGF-b/Smad pathway [23,24].”
BackgroundThe Role of MiR-29 in the Mechanism of Fibrosis
Wang, M., Huo, Z., He, X.-Y., Liu, F., Liang, J., Wu, L., & Yang, D. (2023) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557523666230328125031 · Cited by 41
Application of dental pulp stem cells for bone regeneration
Liu, Y., Xiong, W., Li, J., Feng, H., Jing, S., Liu, Y., Zhou, H., Duan, L., Fu, D., Xu, C., et al. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1339573 · Cited by 46
“Co-Smad, also known as Smad4, is involved in the two pathways (45).”
BackgroundFei, S., Ma, Y., Zhou, B., Chen, X., Zhang, Y., Yue, K., Li, Q., Gui, Y., Xiang, T., Liu, J., et al. (2024) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2024.124261 · Cited by 38
Roles of Smads Family and Alternative Splicing Variants of Smad4 in Different Cancers
Ullah, I., Sun, W., Tang, L., & Feng, J. (2018) · Journal of Cancer · doi:10.7150/jca.20906 · Cited by 38
Chen, G., Liu, L., Sun, J., Zeng, L., Cai, H., & He, Y. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14708 · Cited by 46
Wang, H., Song, X., Liao, H., Wang, P., Zhang, Y., Che, L., Zhang, J., Zhou, Y., Cigliano, A., Ament, C. E., et al. (2020) · Hepatology · doi:10.1002/hep.31692 · Cited by 40
“(15) SMAD7 also facilitates the ubiquitylation and degradation of phosphorylated SMAD2/3 by recruiting E3 ligase Neural precursor cell expressed developmentally downregulated gene 4like to the SMAD2/3SMAD7 heteromeric complex.(16) In addition, SMAD7 may function as a transcriptional repressor.”
BackgroundTargeting the TGF-β signaling pathway for fibrosis therapy: a patent review (2015–2020)
Li, X., Ding, Z., Wu, Z., Xu, Y., Yao, H., & Lin, K. (2021) · Expert Opinion on Therapeutic Patents · doi:10.1080/13543776.2021.1896705 · Cited by 38
“In the canonical pathway, the active TGF-β receptor phosphorylates SMAD2 and SMAD3, which in turn recruits SMAD4 to regulate the transcription of profibrogenic genes, while inhibitory SMAD6 and SMAD7 provide negative feedback to inhibit fibrosis [14].”
BackgroundModulation of host cell signaling during cytomegalovirus latency and reactivation
Smith, N. A., Chan, G. C. T., & O’Connor, C. M. (2021) · Virology Journal · doi:10.1186/s12985-021-01674-1 · Cited by 41
Chen, J., & Chang, R. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.888563 · Cited by 38
“SMAD6 preferentially inhibits SMAD signaling initiated by the bone morphogenetic protein (BMP) type I receptors ALK-3 and ALK-6, whereas SMAD7 inhibits both transforming growth factor β (TGF-β)- and BMP-induced Smad signaling (Hanyu et al., 2001; Goto et al., 2007; Miyazawa and Miyazono, 2017).”
BackgroundPHF14 enhances DNA methylation of SMAD7 gene to promote TGF-β-driven lung adenocarcinoma metastasis
Tian, H., Liu, C., Yu, J., Han, J., Du, J., Liang, S., Wang, W., Liu, Q., Lian, R., Zhu, T., et al. (2023) · Cell Discovery · doi:10.1038/s41421-023-00528-0 · Cited by 40
SMAD7 methylation as a novel marker in atherosclerosis
Wei, L., Zhao, S., Wang, G., Zhang, S., Luo, W., Qin, Z., Bi, X., Tan, Y., Meng, M., Qin, J., et al. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.01.121 · Cited by 38
TGF-β links glycolysis and immunosuppression in glioblastoma.
Gong, L., Li, J., Xu, D., Wang, J., & Zou, J. (2021) · PubMed · doi:10.14670/hh-18-366 · Cited by 44
Parisi, S., Finelli, C., Fazio, A., Stefano, A. D., Mongiorgi, S., Ratti, S., Cappellini, A., Billi, A. M., Cocco, L., Follo, M. Y., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020827 · Cited by 39
“Furthermore, SMAD7 has been shown to promote hematopoietic stem cell self-renewal in vivo”
BackgroundInfluentialSMADS-Mediate Molecular Mechanisms in Sjögren’s Syndrome
Sisto, M., Ribatti, D., & Lisi, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22063203 · Cited by 37
“SMAD7 binds to the TFG-β-receptor complex, preventing its interaction with, and phosphorylation of SMADs [125], so trans modulating the TGF-β/SMAD signalling by the IFN-γ/STAT pathway.”
Singh, S. P., Gouri, V., & Samant, M. (2023) · Medical Oncology · doi:10.1007/s12032-023-02204-5 · Cited by 37
“TGF-β1 signaling is inhibited by the inhibitory SMADs (I-SMADs), SMAD6 and SMAD7, which compete with R-SMAD (SMAD2/3) for receptor binding and flag TGF-β receptors toward ubiquitination [19].”
BackgroundHakki, S. S., Bozkurt, Ş. B., Sculean, A., & Božić, D. (2023) · Journal of Periodontal Research · doi:10.1111/jre.13201 · Cited by 36
Inflammation accelerating intestinal fibrosis: from mechanism to clinic
Xin, S., Liu, X., He, C., Gao, H., Wang, B., Hua, R., Gao, L., Shang, H., Sun, F., & Xu, J. (2024) · European journal of medical research · doi:10.1186/s40001-024-01932-2 · Cited by 39
“Smad6 antagonizes the Smad pathway activated by bone morphogenetic protein (BMP) type I receptors ALK-3 and ALK-6, whereas Smad7 inhibited Smad signaling via TGF-β and BMP [72].”
BackgroundXiao, P., Zhu, Z., Du, C., Zeng, Y., Liao, J., Cheng, Q., Chen, H., Zhao, C., & Huang, W. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02202-2 · Cited by 36
SMAD6-deficiency in human genetic disorders
Luyckx, I., Verstraeten, A., Goumans, M., & Loeys, B. (2022) · npj Genomic Medicine · doi:10.1038/s41525-022-00338-5 · Cited by 38
Park, B., Hwang, E., Seo, S. A., Zhang, M., Park, S., & Yi, T. (2017) · Journal of Functional Foods · doi:10.1016/j.jff.2017.07.028 · Cited by 37
Myocardial Bmp2 gain causes ectopic EMT and promotes cardiomyocyte proliferation and immaturity
Prados, B., Gómez-Apiñániz, P., Papoutsi, T., Luxán, G., Zaffran, S., Pérez-Pomares, J. M., & de la Pompa, J. L. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-0442-z · Cited by 35
The relationship between TGF-β1 and cognitive function in the brain
Su, C., Miao, J., & Guo, J. (2023) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2023.110820 · Cited by 36
“Notable I-Smads encompass Smad6 and Smad7 (Miyazawa and Miyazono, 2017; Murayama et al., 2020) (Fig.”
Lee, C.-M., He, C.-H., Park, J. W., Lee, J., Kamle, S., Ma, B., Akosman, B., Cotez, R., Chen, E., Zhou, Y., et al. (2019) · Life Science Alliance · doi:10.26508/lsa.201900350 · Cited by 35
RetractedMesenchymal MACF1 Facilitates SMAD7 Nuclear Translocation to Drive Bone Formation
Zhao, F., Ma, X., Qiu, W., Wang, P., Zhang, R., Chen, Z., Su, P., Zhang, Y., Li, D., Ma, J., et al. (2020) · Cells · doi:10.3390/cells9030616 · Cited by 34
“In the canonical TGF-β/BMP signaling, SMAD7 serves as an inhibitory SMAD to inhibit bone formation in a negative feedback way [37,41].”
BackgroundSB431542-Loaded Liposomes Alleviate Liver Fibrosis by Suppressing TGF-β Signaling
Zhang, J., Li, R., Liu, Q., Zhou, J., Huang, H., Huang, Y., Zhang, Z., Wu, T., Tang, Q., Huang, C., et al. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00633 · Cited by 34
Fink, M., & Wrana, J. L. (2022) · Developmental Dynamics · doi:10.1002/dvdy.500 · Cited by 34
“They demonstrate diverse modes of actions, competing with R-Smads to bind type I receptors, interfering with R-Smad-Smad4 complex formation, and recruiting ubiquitin ligases, such as Smurf1/2, to promote receptor degradation.(41) Canonical TGF-β signal transduction has been extensively reviewed,(30) yet further flexib…”
BackgroundZhu, W., Cui, Y., Qiu, J., Zhang, X., Gao, Y., Shang, Z., & Huang, L. (2025) · Journal of Clinical and Translational Hepatology · doi:10.14218/jcth.2025.00029 · Cited by 34
“31 SMAD7 binds directly to activated type I TGF-β receptors, occupying the same kinase surface that would normally dock SMAD2/3.”
Developmental SMAD6 loss leads to blood vessel hemorrhage and disrupted endothelial cell junctions
Wylie, L. A., Mouillesseaux, K. P., Chong, D. C., & Bautch, V. L. (2018) · Developmental Biology · doi:10.1016/j.ydbio.2018.07.027 · Cited by 35
Li, J., Yao, H., Huang, J., Li, C., Zhang, Y., Xu, R., Wang, Z., Long, Z., Tang, J. H., & Wang, L. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-05162-4 · Cited by 33
Dysregulation of the immune response in TGF-β signalopathies
Rodari, M. M., Cerf–Bensussan, N., & Parlato, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1066375 · Cited by 34
“In addition, the expression of SMAD6 and SMAD7 induced by TGF-b family members also triggers negative feedback (22).”
BackgroundBayat, Z., Ghaemi, Z., Behmanesh, M., & Soltani, B. M. (2021) · Biological Chemistry · doi:10.1515/hsz-2019-0407 · Cited by 32
Transforming Growth Factor-β1 in Cancer Immunology: Opportunities for Immunotherapy
Villar, V. H., Subotički, T., Đikić, D., Ajtić, O. M., Simón, F., & Santibanez, J. F. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-26163-3_17 · Cited by 33
Informatics approaches to understanding TGFβ pathway regulation
Kahlem, P., & Newfeld, S. J. (2009) · Development · doi:10.1242/dev.030320 · Cited by 36
TMEPAI family: involvement in regulation of multiple signalling pathways
Itoh, S., & Itoh, F. (2018) · The Journal of Biochemistry · doi:10.1093/jb/mvy059 · Cited by 32
SMAD6 is frequently mutated in nonsyndromic radioulnar synostosis
Yang, Y., Yu, Z., Li, W., Li, L., Tu, M., Liu, Z., Mei, H., Zhu, G., & Zhu, Y. (2019) · Genetics in Medicine · doi:10.1038/s41436-019-0552-8 · Cited by 33
“This inhibitor consists of 496 amino acids with an amino-terminal region (N domain) and a conserved carboxyterminal MH2 domain.(25) We identified a total of 27 rare variants (19 LOF and 8 missense) on SMAD6 that occurred in 24/125 sporadic cases and 3/10 families with nsRUS.”
BackgroundESRRB Inhibits the TGFβ Signaling Pathway to Drive Cell Proliferation in Cervical Cancer
Li, Q.-S., & Zheng, P. (2023) · Cancer Research · doi:10.1158/0008-5472.can-23-0067 · Cited by 31
Anticancer drugs: How to select small molecule combinations?
Nussinov, R., Yavuz, B. R., & Jang, H. (2024) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2024.04.012 · Cited by 31
Chanda, A., Sarkar, A., & Bonni, S. (2018) · Cancers · doi:10.3390/cancers10080264 · Cited by 33
Dual role of TGF-β in early pregnancy: clues from tumor progression
Latifi, Z., Nejabati, H. R., Abroon, S., Mihanfar, A., Farzadi, L., Hakimi, P., Hajipour, H., Nouri, M., & Fattahi, A. (2019) · Biology of Reproduction · doi:10.1093/biolre/ioz024 · Cited by 31
Wang, X., Song, C., Ye, Y., Gu, Y., Li, X., Chen, P., Leng, D., Xiao, J., Wu, H., Xie, S., et al. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad907 · Cited by 32
“…through auto-and cross-induced TGF-β isoforms and target transcription factors (55), negative feedback through inhibitory SMADs, SMAD6 and SMAD7 ( 56), recycling of activated SMADs by dephosphorylation and poly(ADP)-ribosylation (57), or removal by polyubiquitylation and proteasome-dependent…”
BackgroundWei, L., Chao, N., Gao, S., Yu, Y., Shi, L., Ma, X., Liao, N., Lan, K., Luo, Y., Xie, Z.-Y., et al. (2018) · Microvascular Research · doi:10.1016/j.mvr.2018.05.003 · Cited by 30
Hesse, E., & Taipaleenmäki, H. (2019) · Current Osteoporosis Reports · doi:10.1007/s11914-019-00510-4 · Cited by 30
E3 Ubiquitin Ligases: Key Regulators of TGFβ Signaling in Cancer Progression
Sinha, A., Iyengar, P. V., & ten Dijke, P. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22020476 · Cited by 34
Ma, G., Chen, F., Liu, Y., Zheng, L., Jiang, X., Tian, H., Wang, X., Song, X., Yu, Y., & Wang, D. (2021) · The FASEB Journal · doi:10.1096/fj.202101332r · Cited by 31
Yang, F., Zhai, Z., Luo, X., Luo, G., Zhuang, L., Zhang, Y., Li, Y., Sun, E., & He, Y. (2019) · Clinical Rheumatology · doi:10.1007/s10067-019-04751-7 · Cited by 30
miR-1306 Mediates the Feedback Regulation of the TGF-β/SMAD Signaling Pathway in Granulosa Cells
Yang, L., Du, X., Liu, L., Cao, Q., Pan, Z., & Li, Q. (2019) · Cells · doi:10.3390/cells8040298 · Cited by 29
Endostatin in fibrosis and as a potential candidate of anti-fibrotic therapy
Zhang, Z., Liu, X., Shen, Z., Quan, J., Lin, C., Li, X., & Hu, G. M. (2021) · Drug Delivery · doi:10.1080/10717544.2021.1983071 · Cited by 31
Photobiomodulation at 830 nm Stimulates Migration, Survival and Proliferation of Fibroblast Cells
Oyebode, O. A., & Houreld, N. N. (2022) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s374649 · Cited by 32
“TGF-β acts as a growth factor that is effective in stimulating wound repair processes.(57) The major intracellular mediators of TGFβ family members are the Smad proteins which makes the TGFβ/Smad signaling pathway important for wound healing.”
BackgroundPTPN3 acts as a tumor suppressor and boosts TGF‐β signaling independent of its phosphatase activity
Yuan, B., Liu, J., Cao, J., Yu, Y., Zhang, H., Wang, F., Zhu, Y., Xiao, M., Liu, S., Ye, Y., et al. (2019) · The EMBO Journal · doi:10.15252/embj.201899945 · Cited by 28
BMP9 is a potential therapeutic agent for use in oral and maxillofacial bone tissue engineering
Liu, L., Chen, Y., Song, D., & Huang, D. (2020) · Biochemical Society Transactions · doi:10.1042/bst20200376 · Cited by 28
Transforming growth f actor‐beta1 and m yeloid‐derived suppressor cells: A cancerous partnership
Mojsilović, S. B., Mojsilović, S. S., Bjelica, S., & Santibanez, J. F. (2021) · Developmental Dynamics · doi:10.1002/dvdy.339 · Cited by 28
“Meanwhile, the TGFβ1-Smad pathway also has a negative feedback mechanism mediated by the inhibitory Smad7 that competitively binds to TβR1 and blocks the Smad intracellular signal transduction.(26,27) Moreover, betaglycan, also named TβR3, binds TGF-β1 with high affinity and promotes TGF-β1 signaling by forming comple…”
Background20 years of Hepcidin: How far we have come
Colucci, S., Marques, O., & Altamura, S. (2021) · Seminars in Hematology · doi:10.1053/j.seminhematol.2021.05.001 · Cited by 30
Zakrzewski, P. K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10173900 · Cited by 29
Yu, J., Zhao, X., Yan, X., Li, W., Liu, Y., Wang, J., Wang, J., Yang, Y., Hao, Y., Liang, Z., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154793 · Cited by 28
Ikeno, S., Nakano, N., Sano, K., Minowa, T., Sato, W., Akatsu, R., Sakata, N., Hanagata, N., Fujii, M., Itoh, F., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.004153 · Cited by 30
Liu, K., Tian, F., Chen, X., Liu, B., Tian, S., Hou, Y., Wang, L., Han, M., Peng, S., Tan, Y., et al. (2024) · Advanced Science · doi:10.1002/advs.202402327 · Cited by 28
The Role of Bone Morphogenetic Proteins in Diabetic Complications
Perera, N., Ritchie, R. H., & Tate, M. (2019) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.9b00064 · Cited by 30
Chen, G., Huang, S., Song, F., Zhou, Y., & He, X. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108354 · Cited by 27
PRMT5 Enables Robust STAT3 Activation via Arginine Symmetric Dimethylation of SMAD7
Cai, C., Gu, S., Yu, Y., Zhu, Y., Zhang, H., Yuan, B., Shen, L., Yang, B., & Feng, X. (2021) · Advanced Science · doi:10.1002/advs.202003047 · Cited by 28
Extracellular CIRP Induces an Inflammatory Phenotype in Pulmonary Fibroblasts via TLR4
Bolourani, S., Sari, E., Brenner, M., & Wang, P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.721970 · Cited by 30
Santos, A. S., Cunha‐Neto, E., Gonfinetti, N. V., Bertonha, F. B., Brochet, P., Bergon, A., Moreira‐Filho, C. A., Chevillard, C., & da Silva, M. E. R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2021.765264 · Cited by 37
“The lowered expression of the anti-inflammatory SMAD6 can also disturb the immunological tolerance in recent-onset T1D (42).”
BackgroundThe role of long non-coding RNA FGD5-AS1 in cancer
He, N. S. M., Xiang, L.-B., Chen, L., Tong, H., Wang, K., Zhao, J., Song, F., Yang, H., Wei, X., & Jiao, Z. (2022) · Bioengineered · doi:10.1080/21655979.2022.2067292 · Cited by 27
Histone Lysine Methylation Modification and Its Role in Vascular Calcification
Cao, Y.-C., Shan, S., Guo, B., Li, C., Li, F., Zheng, M.-H., Xu, Q.-S., Wang, Y., Lei, L.-M., Tang, K.-X., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.863708 · Cited by 27
Regulation and Signaling of TGF-β Autoinduction.
Hariyanto, N. I., Yo, E. C., & Wanandi, S. I. (2021) · PubMed Central · doi:10.22088/ijmcm.bums.10.4.234 · Cited by 27
Ubiquitin‐specific peptidases: Players in bone metabolism
Shen, J., Lin, X., Dai, F., Chen, G., Lin, H., Fang, B., & Liu, H. (2023) · Cell Proliferation · doi:10.1111/cpr.13444 · Cited by 27
Non-hormonal mediators of uterine fibroid growth
Cetin, E. C., Al-Hendy, A. A., & Ciebiera, M. (2020) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000650 · Cited by 30
Zhu, M., Zhang, N., Ma, J., & He, S. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110230 · Cited by 27
The role of cytokine and immune responses in intestinal fibrosis
Yang, B., Zhang, G., Elias, M. G., Zhu, Y., & Wang, J. (2020) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12879 · Cited by 26
“Smad6/7 compete with Smad2/3 for TGF-β receptor I kinase, promote the degradation of TGF−β receptor and negatively regulate the TGFβ/Smad2-3 signaling pathway.(22) Thus, it is not surprising that Smad7 is reported to have a lower expression level in mucosa overlying strictured gut than the non-strictured area.”
BackgroundLi, B., Wang, J., Xu, F., Wang, Q., Liu, Q., Wang, G., Miao, D., & Sun, Q. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10408-x · Cited by 28
Li, X. M., Kim, S. J., Hong, D., Jung, K. E., Choi, C. W., Seo, Y., Lee, J., Lee, Y., & Kim, C. D. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.07.011 · Cited by 27
Bone morphogenetic protein signaling in breast cancer progression
Chi, L. H., Burrows, A. D., & Anderson, R. L. (2019) · Growth Factors · doi:10.1080/08977194.2019.1626378 · Cited by 29
“However, it should be noted that in addition to the conventional ligand-R-SMAD (receptorregulated SMAD) specificity where BMPs induce p-SMADs1/5/8, and TGFb or activins induce pSMADs2/3 (Lagna et al. 1996), the opposite utilization of R-SMADs can occur (Figure 1, dashed lines).”
BackgroundInfluentialCanonical and Non-canonical TGFβ Signaling Activate Autophagy in an ULK1-Dependent Manner
Trelford, C. B., & Guglielmo, G. M. D. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.712124 · Cited by 27
“Although autophagy is important for cellular homeostasis and survival, the protective functions of autophagy act as a double-edged sword in tumorigenesis (Eskelinen, 2011; Moscat and Diaz-Meco, 2012).”
BackgroundBMP2 as a promising anticancer approach: functions and molecular mechanisms
Li, T., Lai, Y.-W., Han, X., Niu, X., & Zhang, P.-X. (2022) · Investigational New Drugs · doi:10.1007/s10637-022-01298-4 · Cited by 29
Han, T., Song, P., Wu, Z., Liu, Y., Ying, W., & Shen, C. (2023) · Stem Cell Reviews and Reports · doi:10.1007/s12015-023-10560-y · Cited by 25
Protective effect of trimetazidine in radiation-induced cardiac fibrosis in mice
Zhang, J., He, X., Bai, X., Sun, Y., Jiang, P., Wang, X., Li, W., & Zhang, Y. (2020) · Journal of Radiation Research · doi:10.1093/jrr/rraa043 · Cited by 24
Metadata
- Authors
- Miyazawa, K., & Miyazono, K.
- Affiliations
- University of Yamanashi (JP)
- The University of Tokyo (JP)
- Venue
- Cold Spring Harbor Perspectives in Biology
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-12-05
- Volume
- 9
- Issue
- 3
- Pages
- a022095
- ISSN
- 1943-0264 (ISSN-L)
- PMC
- PMC5334261
- OpenAlex
- W2560615789
- Cited by
- 439
- References
- 211
- Citations by year
- 2026: 25 · 2025: 32 · 2024: 43 · 2023: 56 · 2022: 61 · 2021: 78 · 2020: 56 · 2019: 33 · 2018: 32 · 2017: 19 · 2016: 2
- Type
- posted content
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Cold Spring Harbor Perspectives in Biology (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Japan Society for the Promotion of Science (15H05774)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Developmental Biology and Gene Regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Hippo pathway signaling and YAP/TAZ
- Keywords
- inhibitory Smads, Smad6, Smad7, TGF-beta signaling, BMP signaling, Smad activation, receptor stability, non-Smad signaling, post-translational modification, phosphorylation, ubiquitination, acetylation, methylation
- MeSH terms
- Animals, Humans, Protein Conformation, Protein Processing, Post-Translational, Signal Transduction, Transforming Growth Factor beta, Smad Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.